AINewsnow

Brainomix E-Lung Analysis Detects Treatment Effects in Phase 2a IPF Trial

This story is from 2026-09-08. It is preserved in the archive; the latest stories are on the live feed.

Brainomix and Endeavor BioMedicines announced positive results on September 8, 2026, from an AI-driven quantitative analysis of CT imaging data collected in Endeavor’s Phase 2a trial of taladegib in idiopathic pulmonary fibrosis, with the findings presented at the European Respiratory Society Congr…

Read the full story at Unite.AI ↗

Timeline · 1 report

  1. 2026-09-08 12:08 · Unite.AI
    Brainomix E-Lung Analysis Detects Treatment Effects in Phase 2a IPF Trial

More stories

  1. Introducing Kimi K3 on Amazon Bedrock — AWS Machine Learning Blog
  2. Introducing Amazon SageMaker HyperPod Inference Gateway — AWS Machine Learning Blog
  3. Anthropic, OpenAI, SpaceXAI, Google sued over call to ‘pace’ AI development — Politico Technology
  4. Gemini Hacked Three Companies in First Known Breakout by Google’s AI — Wall Street Journal Technology
  5. Alibaba ships Qwen3.8-Omni-Flash to watch, listen and call tools — r/LocalLLM
  6. NVIDIA CEO Jensen Huang rejects ‘AI will end the world’ claim, yet cautions ‘we should go as fast as we can but...’ — Mint AI
  7. Meet the Data Agent in ChatGPT Work — OpenAI YouTube
  8. Qwen Image 2.1 PR to ComfyUI — r/StableDiffusion

Get the daily brief of stories like this at 6:30 every morning →